Aurion Biotech to Give Oral Presentation on Regenerative Cell Therapy for Corneal Endothelial Disease at ASGCT 2026

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)-- #ASGCT--Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting, taking place in Boston May 11-15. “We look forward to presenting at ASGCT on our lead investigational cell therapy AURN001, a potential first-in-cla